Revvity Signals

Revvity Signals Revvity Signals Software provides leading software solutions to identify critical data insights and accelerate scientific innovation.

Revvity Signals Software has more than three decades providing unrivaled support for scientific workflows. Our powerful informatics solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. Now under our comprehensive Signals One, our end-to-end SaaS solution integrates workflows across biology, chemistry and materials new product development to acc

elerate scientific innovation, and help scientists help each other. In addition, our robust solution, powered by TIBCO® Spotfire®, can revolutionize the clinical trial process. From our internationally recognized flagship ChemDraw® and E-Notebook applications, to our Signals One (Signals Notebook, Signals VitroVivo and Signals Inventa) to our exclusive TIBCO® Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.

Every successful ELN rollout has champions behind it.The scientists who embrace the platform, help colleagues, and share...
08/05/2026

Every successful ELN rollout has champions behind it.

The scientists who embrace the platform, help colleagues, and share best practices often play the biggest role in driving adoption.

Our latest blog explores proven strategies to build and nurture an ELN power user community: http://ms.spr.ly/6181aEDyc

Behind every great internship is the opportunity to make a real impact.This National Intern Day, we're spotlighting our ...
07/30/2026

Behind every great internship is the opportunity to make a real impact.

This National Intern Day, we're spotlighting our Marketing Intern, Yazan Hailat, whose AI projects have helped automate workflows across our organization.

👇Learn more about Yazan's experience and join us in celebrating all of our interns for their incredible contributions!

07/27/2026

Attention biotech founders: Your biggest scaling challenge may not be your science. It may be your workflows.

Learn why building the right digital foundation early can help your team move faster as you grow.

Read the blog: http://ms.spr.ly/6182v7uSp

07/23/2026

If your biology workflows feel like a Frankenstack, you're not alone.

Signals BioDesign helps replace disconnected tools with integrated, scalable workflows built alongside the scientists who use them every day. See what's possible: http://ms.spr.ly/6181vArtP

Scientific AI isn't about replacing scientists. It's about building better collaborators. In our latest blog, Revvity Si...
07/08/2026

Scientific AI isn't about replacing scientists. It's about building better collaborators.

In our latest blog, Revvity Signals Chief Strategy Officer Dr. David Gosalvez explores what it will take for AI to become a trusted scientific partner: one that reasons, calculates, and works with scientists to support better decisions.

Read more: http://ms.spr.ly/6183vxJOv

06/26/2026

Labs have invested heavily in ELNs, LIMS, and LES platforms. Yet complex workflows can still slow research down.

The missing piece isn't another point solution. It's a coordination layer that connects systems, data, and decisions across R&D. Learn more in our latest blog: http://ms.spr.ly/6189vULWT

06/15/2026

Novartis is onboarding around 4,000 biologists to Signals to streamline workflows, accelerate research and work from one unified platform.

What's next? Leveraging AI to uncover insights hidden within complex datasets.

Hear more from Maggie Pancost-Heidebrecht in the full customer video. 👇

How is your team managing the complexity of rare disease research?From fragmented data to complex collaborations, many R...
06/11/2026

How is your team managing the complexity of rare disease research?

From fragmented data to complex collaborations, many R&D teams are working around challenges their tools weren't built to solve.

See how digital solutions can help: http://ms.spr.ly/6182vg4mu

05/27/2026

Scientific software should accelerate discovery, not slow it down.

AstraZeneca transitioned 3,800 scientists to Signals Notebook in just 18 months, streamlining workflows and accelerating R&D. See how your organization can accelerate R&D in our latest blog: http://ms.spr.ly/6185vkRQF

05/20/2026

Staying compliant shouldn’t mean slowing discovery.

When implemented thoughtfully, SaaS solutions like Signals Notebook and Signals One can cut through validation complexity, helping teams accelerate compliance while staying focused on what matters most: doing science.

Because validation doesn’t have to be a bottleneck. It can be your quiet advantage. New blog: http://ms.spr.ly/6183vpOHX

Address

77 4th Avenue
Waltham, MA
02451

Telephone

+18007624000

Website

Alerts

Be the first to know and let us send you an email when Revvity Signals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category